Browsing: Gynecological

In this Chinese phase 3 trial, 94 patients receiving definitive chemoradiation (50.4 Gy in 28 fractions or 45 Gy in…

This editorial argues the key to cost effect screening and primary prevention of ovarian cancer doesn’t lie in new screening…

An eye-opening look-back at 1377 women treated for high-grade serous ovarian cancer at Hopkins and MSKCC between 2015-2021 revealed nearly…

Top Line: Does the type of brachytherapy applicator influence treatment outcomes or toxicity in cervical cancer patients?The Study: Tandem and…

Anyone who has performed brachytherapy for cervical cancer has likely encountered the conundrum of managing a concurrent thromboembolism. This practical…

A randomized trial reported non-inferior local control with simple hysterectomy (sparing parametria and upper vagina and thus urinary toxicity) versus…

A randomized trial reported non-inferior local control with simple hysterectomy (sparing parametria and upper vagina and thus urinary toxicity) versus…

A randomized trial reported non-inferior local control with simple hysterectomy (sparing parametria and upper vagina and thus urinary toxicity) versus…

A randomized trial reported non-inferior local control with simple hysterectomy (sparing parametria and upper vagina and thus urinary toxicity) versus…

A randomized trial reported non-inferior local control with simple hysterectomy (sparing parametria and upper vagina and thus urinary toxicity) versus…